| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 NID2 THBS2 MEGF6 MEGF8 DLL4 TLL2 LRP2 UMOD PLA2G10 LTBP1 PKD1L2 ADGRE2 LDLR SVEP1 CRB2 STAB1 | 1.70e-08 | 749 | 86 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.18e-07 | 188 | 86 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 8.61e-07 | 120 | 86 | 7 | GO:0004222 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 9.37e-07 | 18 | 86 | 4 | GO:0030169 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.78e-06 | 85 | 86 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.81e-06 | 21 | 86 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS12 ADAMTS19 ADAMTS7 ADAMTS6 TLL2 ADAMTS16 ADAMTS5 XPNPEP2 | 2.39e-06 | 200 | 86 | 8 | GO:0008237 |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.22e-06 | 27 | 86 | 4 | GO:0005044 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 1.52e-05 | 35 | 86 | 4 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 1.52e-05 | 35 | 86 | 4 | GO:0071814 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 1.65e-05 | 12 | 86 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.15e-05 | 16 | 86 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 5.48e-05 | 3 | 86 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS12 KLK15 ADAMTS19 HGFAC ADAMTS7 ADAMTS6 TLL2 ADAMTS16 ADAMTS5 | 9.73e-05 | 430 | 86 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.58e-04 | 268 | 86 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | Notch binding | 2.09e-04 | 27 | 86 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | peptidase activity | ADAMTS12 KLK15 ADAMTS19 HGFAC ADAMTS7 ADAMTS6 TLL2 ADAMTS16 ADAMTS5 XPNPEP2 | 5.00e-04 | 654 | 86 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | heparin binding | 1.45e-03 | 192 | 86 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.72e-03 | 323 | 86 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.86e-03 | 73 | 86 | 3 | GO:0050840 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS12 ADAMTS19 NID2 TIE1 ADAMTS7 ADAMTS6 TLL2 ADAMTS16 LAMB1 LAMB2 PAPLN ADAMTS5 ADAMTSL4 | 4.01e-09 | 377 | 84 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS12 ADAMTS19 NID2 TIE1 ADAMTS7 ADAMTS6 TLL2 ADAMTS16 LAMB1 LAMB2 PAPLN ADAMTS5 ADAMTSL4 | 4.14e-09 | 378 | 84 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS12 ADAMTS19 NID2 TIE1 ADAMTS7 ADAMTS6 TLL2 ADAMTS16 LAMB1 LAMB2 PAPLN ADAMTS5 ADAMTSL4 | 4.27e-09 | 379 | 84 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 2.15e-07 | 63 | 84 | 6 | GO:0007157 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 2.25e-06 | 7 | 84 | 3 | GO:0043654 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | TGFB1I1 ADAMTS12 JAG2 FRAS1 MEGF8 TIE1 DLL4 ADAMTS16 LRP2 PLA2G10 ADAMTS5 CSMD1 CRB2 | 1.01e-05 | 750 | 84 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | artery development | 1.73e-05 | 133 | 84 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | aorta development | 1.88e-05 | 80 | 84 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.89e-05 | 39 | 84 | 4 | GO:0003180 | |
| GeneOntologyBiologicalProcess | epithelium development | TGFB1I1 ADAMTS12 JAG2 FRAS1 MEGF8 TIE1 MYO7A DLL4 ADAMTS16 PLXNA4 LRP2 UMOD LAMB2 PLA2G10 CSMD1 ADAMTSL4 PLXNA2 CRB2 | 2.07e-05 | 1469 | 84 | 18 | GO:0060429 |
| GeneOntologyBiologicalProcess | phosphatidylcholine catabolic process | 3.51e-05 | 16 | 84 | 3 | GO:0034638 | |
| GeneOntologyBiologicalProcess | aortic valve development | 3.67e-05 | 46 | 84 | 4 | GO:0003176 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | TGFB1I1 ADAMTS12 JAG2 FRAS1 MEGF8 TIE1 DLL4 ADAMTS16 LRP2 PLA2G10 CSMD1 | 4.15e-05 | 619 | 84 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in axon guidance | 4.25e-05 | 17 | 84 | 3 | GO:0048841 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | PLXNA3 THBS2 TENM4 MEGF8 DLL4 ADGRB3 PLXNA4 LRP2 ADGRE2 LDLR PLXNA2 | 4.53e-05 | 625 | 84 | 11 | GO:0051960 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 ADAMTS19 FRAS1 MEGF8 TENM3 MYO7A DLL4 ADAMTS16 MUC19 LRP2 LAMB1 LAMB2 ADAMTS5 CSMD1 MEGF11 CRB2 | 4.60e-05 | 1269 | 84 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylcholine catabolic process | 4.90e-05 | 3 | 84 | 2 | GO:0010899 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 5.09e-05 | 418 | 84 | 9 | GO:0051962 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 5.11e-05 | 50 | 84 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | neuron development | SCARF1 PLXNA3 TENM4 MEGF8 TENM3 MYO7A ADGRB3 PLXNA4 TENM1 LRP2 LAMB1 LAMB2 PLA2G10 CSMD3 PRAG1 PLXNA2 CRB2 | 7.13e-05 | 1463 | 84 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 9.49e-05 | 22 | 84 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 9.49e-05 | 22 | 84 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.27e-04 | 63 | 84 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | SCARF1 PLXNA3 LIMK2 MEGF8 TENM3 ADAMTS16 ADGRB3 PLXNA4 TENM1 CSMD3 PRAG1 PLXNA2 | 1.57e-04 | 846 | 84 | 12 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.63e-04 | 5 | 84 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.63e-04 | 285 | 84 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.67e-04 | 286 | 84 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | SCARF1 PLXNA3 LIMK2 MEGF8 TENM3 ADAMTS16 ADGRB3 PLXNA4 TENM1 CSMD3 PRAG1 PLXNA2 | 1.88e-04 | 863 | 84 | 12 | GO:0031344 |
| GeneOntologyBiologicalProcess | circulatory system development | ADAMTS19 THBS2 TENM4 MEGF8 TIE1 ADAMTS6 DLL4 ADGRB3 PLXNA4 LRP2 LTBP1 ADAMTS5 LDLR SVEP1 CRB2 STAB1 | 2.05e-04 | 1442 | 84 | 16 | GO:0072359 |
| GeneOntologyBiologicalProcess | trigeminal nerve morphogenesis | 2.43e-04 | 6 | 84 | 2 | GO:0021636 | |
| GeneOntologyBiologicalProcess | trigeminal nerve structural organization | 2.43e-04 | 6 | 84 | 2 | GO:0021637 | |
| GeneOntologyBiologicalProcess | response to BMP | 2.47e-04 | 215 | 84 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 2.47e-04 | 215 | 84 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.63e-04 | 76 | 84 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | heart valve development | 2.90e-04 | 78 | 84 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | ADAMTS12 GPR137 PLXNA3 THBS2 TIE1 ADAMTS7 DLL4 PRG2 PELI3 ADGRB3 TNFRSF13B PLA2G10 ADAMTS5 LDLR SVEP1 STAB1 | 2.93e-04 | 1488 | 84 | 16 | GO:0051241 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.40e-04 | 7 | 84 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | branchiomotor neuron axon guidance | 3.40e-04 | 7 | 84 | 2 | GO:0021785 | |
| GeneOntologyBiologicalProcess | regulation of phospholipid catabolic process | 3.40e-04 | 7 | 84 | 2 | GO:0060696 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 3.68e-04 | 83 | 84 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 3.88e-04 | 35 | 84 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 4.52e-04 | 8 | 84 | 2 | GO:0045959 | |
| GeneOntologyBiologicalProcess | glycerophospholipid catabolic process | 4.58e-04 | 37 | 84 | 3 | GO:0046475 | |
| GeneOntologyBiologicalProcess | tube development | ADAMTS12 THBS2 MEGF8 TIE1 DLL4 ADAMTS16 ADGRB3 PLXNA4 MUC19 LRP2 UMOD CSMD1 LDLR PLXNA2 STAB1 | 4.91e-04 | 1402 | 84 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | artery morphogenesis | 5.45e-04 | 92 | 84 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | symbiont entry into host cell | 6.37e-04 | 169 | 84 | 5 | GO:0046718 | |
| GeneOntologyBiologicalProcess | neuron projection development | SCARF1 PLXNA3 MEGF8 TENM3 MYO7A ADGRB3 PLXNA4 LRP2 LAMB1 LAMB2 PLA2G10 CSMD3 PRAG1 PLXNA2 | 6.47e-04 | 1285 | 84 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 6.67e-04 | 42 | 84 | 3 | GO:0006910 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.15e-04 | 43 | 84 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylcholine metabolic process | 7.22e-04 | 10 | 84 | 2 | GO:0150172 | |
| GeneOntologyBiologicalProcess | cholesterol catabolic process | 7.22e-04 | 10 | 84 | 2 | GO:0006707 | |
| GeneOntologyBiologicalProcess | sterol catabolic process | 7.22e-04 | 10 | 84 | 2 | GO:0016127 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 7.22e-04 | 10 | 84 | 2 | GO:0030450 | |
| GeneOntologyBiologicalProcess | facial nerve structural organization | 7.22e-04 | 10 | 84 | 2 | GO:0021612 | |
| GeneOntologyBiologicalProcess | symbiont entry into host | 7.66e-04 | 176 | 84 | 5 | GO:0044409 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 8.54e-04 | 612 | 84 | 9 | GO:0010975 | |
| GeneOntologyBiologicalProcess | antibacterial innate immune response | 8.80e-04 | 11 | 84 | 2 | GO:0140367 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 8.80e-04 | 11 | 84 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | PLXNA3 MEGF8 MYO7A ADGRB3 PLXNA4 LRP2 LAMB1 LAMB2 PLA2G10 PLXNA2 | 9.08e-04 | 748 | 84 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 9.87e-04 | 48 | 84 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | heart development | ADAMTS19 TENM4 MEGF8 TIE1 ADAMTS6 DLL4 PLXNA4 LRP2 LTBP1 ADAMTS5 | 9.94e-04 | 757 | 84 | 10 | GO:0007507 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.05e-03 | 12 | 84 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 1.05e-03 | 12 | 84 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | facial nerve morphogenesis | 1.05e-03 | 12 | 84 | 2 | GO:0021610 | |
| GeneOntologyBiologicalProcess | facial nerve development | 1.05e-03 | 12 | 84 | 2 | GO:0021561 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.05e-03 | 12 | 84 | 2 | GO:0002924 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.18e-03 | 515 | 84 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | axon development | 1.19e-03 | 642 | 84 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.22e-03 | 114 | 84 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | cranial nerve structural organization | 1.24e-03 | 13 | 84 | 2 | GO:0021604 | |
| GeneOntologyBiologicalProcess | trigeminal nerve development | 1.24e-03 | 13 | 84 | 2 | GO:0021559 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.25e-03 | 52 | 84 | 3 | GO:0071526 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.44e-03 | 14 | 84 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.44e-03 | 14 | 84 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 1.44e-03 | 14 | 84 | 2 | GO:0045916 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.44e-03 | 14 | 84 | 2 | GO:0010572 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | ADAMTS12 PLXNA3 THBS2 TENM4 MEGF8 TIE1 ADGRB3 PLXNA4 PRAG1 PLXNA2 CRB2 STAB1 | 1.49e-03 | 1090 | 84 | 12 | GO:0022603 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.65e-03 | 421 | 84 | 7 | GO:0060562 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.66e-03 | 124 | 84 | 4 | GO:0042100 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.75e-03 | 212 | 84 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.75e-03 | 313 | 84 | 6 | GO:0098742 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 1.80e-03 | 59 | 84 | 3 | GO:0085029 | |
| GeneOntologyBiologicalProcess | vasculature development | THBS2 MEGF8 TIE1 ADAMTS6 DLL4 ADGRB3 LRP2 LTBP1 LDLR SVEP1 STAB1 | 1.87e-03 | 969 | 84 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | phospholipid catabolic process | 1.89e-03 | 60 | 84 | 3 | GO:0009395 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.90e-03 | 16 | 84 | 2 | GO:0002713 | |
| GeneOntologyBiologicalProcess | cholesterol import | 1.90e-03 | 16 | 84 | 2 | GO:0070508 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.90e-03 | 16 | 84 | 2 | GO:0002890 | |
| GeneOntologyBiologicalProcess | axonogenesis | 2.14e-03 | 566 | 84 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TGFB1I1 PLXNA3 PDE3A TENM4 MEGF8 PLXNA4 LRP2 LAMB1 LAMB2 PLA2G10 PLXNA2 CRB2 | 2.19e-03 | 1141 | 84 | 12 | GO:0045597 |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.20e-03 | 134 | 84 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | axon extension | 2.26e-03 | 135 | 84 | 4 | GO:0048675 | |
| GeneOntologyCellularComponent | extracellular matrix | TGFB1I1 ADAMTS12 ADAMTS19 NID2 FRAS1 THBS2 MEGF6 ADAMTS7 TIMP3 ADAMTS6 PRG2 ADAMTS16 LAMB1 LAMB2 PAPLN LTBP1 ADAMTS5 SSPOP ADAMTSL4 PLXNA2 SVEP1 LRRC15 | 1.54e-14 | 656 | 86 | 22 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TGFB1I1 ADAMTS12 ADAMTS19 NID2 FRAS1 THBS2 MEGF6 ADAMTS7 TIMP3 ADAMTS6 PRG2 ADAMTS16 LAMB1 LAMB2 PAPLN LTBP1 ADAMTS5 SSPOP ADAMTSL4 PLXNA2 SVEP1 LRRC15 | 1.64e-14 | 658 | 86 | 22 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | TGFB1I1 NID2 FRAS1 THBS2 MEGF6 TIMP3 PRG2 LAMB1 LAMB2 PAPLN LTBP1 ADAMTS5 SSPOP ADAMTSL4 PLXNA2 LRRC15 | 4.38e-10 | 530 | 86 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 7.11e-07 | 122 | 86 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.87e-05 | 13 | 86 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 2.43e-04 | 212 | 86 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | laminin complex | 7.37e-04 | 10 | 86 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | cerebellar climbing fiber to Purkinje cell synapse | 8.98e-04 | 11 | 86 | 2 | GO:0150053 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.19e-03 | 17 | 86 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.49e-03 | 332 | 86 | 6 | GO:0005788 | |
| Domain | EGF | SCARF1 JAG2 NID2 HGFAC FRAS1 THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 LAMB1 UMOD LAMB2 LTBP1 ADGRE2 NAGPA LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 2.15e-32 | 235 | 86 | 28 | SM00181 |
| Domain | EGF-like_dom | SCARF1 JAG2 NID2 HGFAC FRAS1 THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 LAMB1 UMOD LAMB2 LTBP1 ADGRE2 NAGPA LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 1.15e-31 | 249 | 86 | 28 | IPR000742 |
| Domain | EGF_2 | SCARF1 JAG2 NID2 HGFAC THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 LAMB1 UMOD LAMB2 LTBP1 ADGRE2 NAGPA SSPOP LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 6.90e-31 | 265 | 86 | 28 | PS01186 |
| Domain | EGF_1 | SCARF1 JAG2 HGFAC THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 LAMB1 UMOD LAMB2 LTBP1 ADGRE2 NAGPA SSPOP LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 8.73e-30 | 255 | 86 | 27 | PS00022 |
| Domain | EGF-like_CS | SCARF1 JAG2 NID2 HGFAC THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 LAMB1 UMOD LAMB2 LTBP1 ADGRE2 NAGPA LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 1.66e-29 | 261 | 86 | 27 | IPR013032 |
| Domain | EGF_3 | SCARF1 JAG2 NID2 HGFAC THBS2 TENM4 MEGF6 MEGF8 TENM3 TIE1 DLL4 TLL2 TENM1 LRP2 UMOD LTBP1 ADGRE2 NAGPA SSPOP LDLR MEGF11 SVEP1 MEGF10 CRB2 PEAR1 STAB1 | 3.57e-29 | 235 | 86 | 26 | PS50026 |
| Domain | EGF_extracell | SCARF1 JAG2 TENM4 MEGF6 TENM3 TIE1 DLL4 TENM1 LRP2 NAGPA MEGF11 SVEP1 MEGF10 STAB1 | 9.29e-21 | 60 | 86 | 14 | IPR013111 |
| Domain | EGF_2 | SCARF1 JAG2 TENM4 MEGF6 TENM3 TIE1 DLL4 TENM1 LRP2 NAGPA MEGF11 SVEP1 MEGF10 STAB1 | 9.29e-21 | 60 | 86 | 14 | PF07974 |
| Domain | Growth_fac_rcpt_ | SCARF1 JAG2 NID2 FRAS1 MEGF6 MEGF8 TIE1 DLL4 LRP2 LAMB1 UMOD LAMB2 RSPO4 LTBP1 ADGRE2 LDLR SVEP1 STAB1 | 1.35e-20 | 156 | 86 | 18 | IPR009030 |
| Domain | TSP1 | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADGRB3 PAPLN RSPO4 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 2.20e-18 | 65 | 86 | 13 | SM00209 |
| Domain | TSP1_rpt | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADGRB3 PAPLN RSPO4 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 2.20e-18 | 65 | 86 | 13 | IPR000884 |
| Domain | TSP1 | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADGRB3 PAPLN RSPO4 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 2.20e-18 | 65 | 86 | 13 | PS50092 |
| Domain | EGF_CA | JAG2 NID2 THBS2 MEGF6 MEGF8 DLL4 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 STAB1 | 1.02e-17 | 122 | 86 | 15 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | JAG2 NID2 THBS2 MEGF6 MEGF8 DLL4 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 STAB1 | 1.32e-17 | 124 | 86 | 15 | IPR001881 |
| Domain | EGF | JAG2 NID2 HGFAC THBS2 MEGF6 TIE1 DLL4 TLL2 LRP2 UMOD LTBP1 NAGPA SVEP1 CRB2 STAB1 | 1.69e-17 | 126 | 86 | 15 | PF00008 |
| Domain | TSP_1 | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADGRB3 PAPLN ADAMTS5 THSD7B SSPOP ADAMTSL4 | 9.03e-17 | 63 | 86 | 12 | PF00090 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 NID2 MEGF6 MEGF8 DLL4 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 | 1.83e-15 | 106 | 86 | 13 | IPR000152 |
| Domain | EGF_CA | JAG2 NID2 THBS2 MEGF6 MEGF8 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 | 4.75e-15 | 86 | 86 | 12 | PF07645 |
| Domain | EGF_Ca-bd_CS | JAG2 NID2 MEGF6 MEGF8 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 | 2.13e-14 | 97 | 86 | 12 | IPR018097 |
| Domain | EGF_CA | JAG2 NID2 MEGF6 MEGF8 TLL2 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 | 2.74e-14 | 99 | 86 | 12 | PS01187 |
| Domain | ASX_HYDROXYL | JAG2 NID2 MEGF6 MEGF8 DLL4 LRP2 UMOD LTBP1 ADGRE2 LDLR SVEP1 CRB2 | 3.10e-14 | 100 | 86 | 12 | PS00010 |
| Domain | Laminin_EGF | 3.88e-14 | 35 | 86 | 9 | PF00053 | |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS19 ADAMTS7 ADAMTS6 ADAMTS16 PAPLN ADAMTS5 ADAMTSL4 | 6.71e-14 | 23 | 86 | 8 | IPR010294 |
| Domain | ADAM_spacer1 | ADAMTS12 ADAMTS19 ADAMTS7 ADAMTS6 ADAMTS16 PAPLN ADAMTS5 ADAMTSL4 | 6.71e-14 | 23 | 86 | 8 | PF05986 |
| Domain | Laminin_EGF | 8.85e-14 | 38 | 86 | 9 | IPR002049 | |
| Domain | PLAC | 1.65e-12 | 19 | 86 | 7 | PS50900 | |
| Domain | PLAC | 1.65e-12 | 19 | 86 | 7 | IPR010909 | |
| Domain | EGF_Lam | 3.08e-12 | 35 | 86 | 8 | SM00180 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.11e-11 | 24 | 86 | 7 | IPR013273 | |
| Domain | EGF_3 | 1.42e-09 | 12 | 86 | 5 | PF12947 | |
| Domain | EGF_dom | 1.42e-09 | 12 | 86 | 5 | IPR024731 | |
| Domain | YD | 2.09e-09 | 5 | 86 | 4 | IPR006530 | |
| Domain | hEGF | 2.77e-09 | 28 | 86 | 6 | PF12661 | |
| Domain | PLAC | 3.57e-09 | 14 | 86 | 5 | PF08686 | |
| Domain | EMI | 1.09e-08 | 17 | 86 | 5 | PS51041 | |
| Domain | VWC | 1.96e-08 | 38 | 86 | 6 | SM00214 | |
| Domain | VWFC_2 | 1.96e-08 | 38 | 86 | 6 | PS50184 | |
| Domain | VWC_out | 2.03e-08 | 19 | 86 | 5 | SM00215 | |
| Domain | Peptidase_M12B_N | 2.31e-08 | 39 | 86 | 6 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.31e-08 | 39 | 86 | 6 | PF01562 | |
| Domain | - | 2.31e-08 | 39 | 86 | 6 | 2.120.10.30 | |
| Domain | DISINTEGRIN_1 | 2.70e-08 | 40 | 86 | 6 | PS00427 | |
| Domain | Reprolysin | 2.70e-08 | 40 | 86 | 6 | PF01421 | |
| Domain | ADAM_MEPRO | 2.70e-08 | 40 | 86 | 6 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.70e-08 | 40 | 86 | 6 | PS50214 | |
| Domain | Peptidase_M12B | 2.70e-08 | 40 | 86 | 6 | IPR001590 | |
| Domain | Disintegrin_dom | 3.16e-08 | 41 | 86 | 6 | IPR001762 | |
| Domain | VWF_dom | 3.67e-08 | 42 | 86 | 6 | IPR001007 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.45e-08 | 46 | 86 | 6 | IPR011042 | |
| Domain | MetalloPept_cat_dom | 9.04e-08 | 81 | 86 | 7 | IPR024079 | |
| Domain | - | 9.04e-08 | 81 | 86 | 7 | 3.40.390.10 | |
| Domain | - | 1.35e-07 | 11 | 86 | 4 | 2.40.155.10 | |
| Domain | GFP-like | 1.35e-07 | 11 | 86 | 4 | IPR023413 | |
| Domain | ZINC_PROTEASE | 3.38e-07 | 98 | 86 | 7 | PS00142 | |
| Domain | Tox-GHH_dom | 3.76e-07 | 4 | 86 | 3 | IPR028916 | |
| Domain | Ten_N | 3.76e-07 | 4 | 86 | 3 | IPR009471 | |
| Domain | Ten_N | 3.76e-07 | 4 | 86 | 3 | PF06484 | |
| Domain | TENEURIN_N | 3.76e-07 | 4 | 86 | 3 | PS51361 | |
| Domain | Tox-GHH | 3.76e-07 | 4 | 86 | 3 | PF15636 | |
| Domain | TIL_dom | 4.05e-07 | 14 | 86 | 4 | IPR002919 | |
| Domain | VWFC_1 | 6.20e-07 | 36 | 86 | 5 | PS01208 | |
| Domain | EMI_domain | 7.31e-07 | 16 | 86 | 4 | IPR011489 | |
| Domain | CUB | 4.44e-06 | 53 | 86 | 5 | PS01180 | |
| Domain | CUB_dom | 6.38e-06 | 57 | 86 | 5 | IPR000859 | |
| Domain | Plexin_cytopl | 7.76e-06 | 9 | 86 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 7.76e-06 | 9 | 86 | 3 | IPR013548 | |
| Domain | Plexin | 7.76e-06 | 9 | 86 | 3 | IPR031148 | |
| Domain | EGF_LAM_2 | 1.05e-05 | 30 | 86 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.05e-05 | 30 | 86 | 4 | PS01248 | |
| Domain | PSI | 1.37e-05 | 32 | 86 | 4 | PF01437 | |
| Domain | Plexin_repeat | 1.37e-05 | 32 | 86 | 4 | IPR002165 | |
| Domain | Unchr_dom_Cys-rich | 2.61e-05 | 13 | 86 | 3 | IPR014853 | |
| Domain | C8 | 2.61e-05 | 13 | 86 | 3 | SM00832 | |
| Domain | NHL | 2.61e-05 | 13 | 86 | 3 | PS51125 | |
| Domain | Ldl_recept_b | 3.31e-05 | 14 | 86 | 3 | PF00058 | |
| Domain | LDLRB | 3.31e-05 | 14 | 86 | 3 | PS51120 | |
| Domain | LDLR_class-A_CS | 3.37e-05 | 40 | 86 | 4 | IPR023415 | |
| Domain | CYSTEINE_SWITCH | 3.73e-05 | 41 | 86 | 4 | PS00546 | |
| Domain | LY | 4.12e-05 | 15 | 86 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.12e-05 | 15 | 86 | 3 | IPR000033 | |
| Domain | Pept_M10_metallopeptidase | 4.51e-05 | 43 | 86 | 4 | IPR001818 | |
| Domain | PSI | 4.94e-05 | 44 | 86 | 4 | IPR016201 | |
| Domain | VWD | 5.05e-05 | 16 | 86 | 3 | SM00216 | |
| Domain | VWF_type-D | 5.05e-05 | 16 | 86 | 3 | IPR001846 | |
| Domain | VWFD | 5.05e-05 | 16 | 86 | 3 | PS51233 | |
| Domain | VWD | 5.05e-05 | 16 | 86 | 3 | PF00094 | |
| Domain | Ldl_recept_a | 5.41e-05 | 45 | 86 | 4 | PF00057 | |
| Domain | PSI | 5.90e-05 | 46 | 86 | 4 | SM00423 | |
| Domain | - | 5.90e-05 | 46 | 86 | 4 | 4.10.400.10 | |
| Domain | Rhs_assc_core | 6.27e-05 | 3 | 86 | 2 | IPR022385 | |
| Domain | LAMININ_IVB | 6.27e-05 | 3 | 86 | 2 | PS51116 | |
| Domain | Laminin_IV_B | 6.27e-05 | 3 | 86 | 2 | IPR013015 | |
| Domain | LDLRA_1 | 6.99e-05 | 48 | 86 | 4 | PS01209 | |
| Domain | CUB | 7.58e-05 | 49 | 86 | 4 | PF00431 | |
| Domain | LDLRA_2 | 7.58e-05 | 49 | 86 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.58e-05 | 49 | 86 | 4 | IPR002172 | |
| Domain | LDLa | 7.58e-05 | 49 | 86 | 4 | SM00192 | |
| Domain | CUB | 8.21e-05 | 50 | 86 | 4 | SM00042 | |
| Domain | - | 9.58e-05 | 52 | 86 | 4 | 2.60.120.290 | |
| Domain | Sushi | 9.58e-05 | 52 | 86 | 4 | PF00084 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 1.02e-15 | 39 | 64 | 10 | M27417 |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 1.02e-15 | 39 | 64 | 10 | MM15165 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 4.22e-13 | 68 | 64 | 10 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 MUC19 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 1.86e-12 | 109 | 64 | 11 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 6.44e-11 | 111 | 64 | 10 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 7.98e-10 | 143 | 64 | 10 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADAMTS5 THSD7B SSPOP ADAMTSL4 | 1.68e-07 | 250 | 64 | 10 | M27554 |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 7.35e-06 | 9 | 64 | 3 | MM15030 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 3.13e-05 | 14 | 64 | 3 | MM15029 | |
| Pathway | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | 3.13e-05 | 14 | 64 | 3 | M7578 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 3.91e-05 | 15 | 64 | 3 | MM15031 | |
| Pathway | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | 4.79e-05 | 16 | 64 | 3 | M16498 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 4.79e-05 | 16 | 64 | 3 | M8245 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 2.00e-04 | 64 | 64 | 4 | M7923 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.32e-04 | 30 | 64 | 3 | M27216 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.05e-04 | 300 | 64 | 7 | M610 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.20e-04 | 7 | 64 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 7.16e-04 | 9 | 64 | 2 | M47866 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.09e-03 | 11 | 64 | 2 | M158 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS19 THBS2 MEGF6 ADAMTS7 ADAMTS6 ADAMTS16 MUC19 UMOD LTBP1 ADAMTS5 XPNPEP2 THSD7B SSPOP ADAMTSL4 | 1.14e-03 | 1389 | 64 | 15 | MM15307 |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.53e-03 | 13 | 64 | 2 | M47423 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 1.53e-03 | 13 | 64 | 2 | M42551 | |
| Pathway | REACTOME_SEMAPHORIN_INTERACTIONS | 1.59e-03 | 51 | 64 | 3 | MM14967 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 1.88e-03 | 54 | 64 | 3 | M39337 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.05e-03 | 15 | 64 | 2 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.05e-03 | 15 | 64 | 2 | M27202 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 LAMB1 UMOD LAMB2 LTBP1 ADAMTS5 XPNPEP2 THSD7B SSPOP ADAMTSL4 | 2.08e-03 | 1475 | 64 | 15 | M19806 |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.34e-03 | 16 | 64 | 2 | M47424 | |
| Pathway | PID_NOTCH_PATHWAY | 2.42e-03 | 59 | 64 | 3 | M17 | |
| Pathway | WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES | 2.64e-03 | 17 | 64 | 2 | M39747 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 2.64e-03 | 17 | 64 | 2 | M39389 | |
| Pathway | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | 3.30e-03 | 19 | 64 | 2 | M10959 | |
| Pathway | WP_STATIN_PATHWAY | 3.30e-03 | 19 | 64 | 2 | MM15868 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.30e-03 | 19 | 64 | 2 | MM15594 | |
| Pathway | WP_CHOLESTASIS | 3.30e-03 | 19 | 64 | 2 | M45520 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 3.33e-03 | 66 | 64 | 3 | M18 | |
| Pubmed | ADAMTS12 ADAMTS19 THBS2 ADAMTS7 ADAMTS6 ADAMTS16 ADGRB3 PAPLN ADAMTS5 THSD7B SSPOP ADAMTSL4 | 7.24e-19 | 75 | 88 | 12 | 20637190 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | NID2 THBS2 ADAMTS7 TIMP3 LAMB1 LAMB2 LTBP1 ADAMTS5 ADAMTSL4 LDLR SVEP1 | 3.83e-11 | 248 | 88 | 11 | 24006456 |
| Pubmed | 7.94e-09 | 10 | 88 | 4 | 11167130 | ||
| Pubmed | 1.60e-08 | 175 | 88 | 8 | 28071719 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 5.29e-08 | 79 | 88 | 6 | 18757743 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 6.25e-08 | 4 | 88 | 3 | 10225957 | |
| Pubmed | 6.25e-08 | 4 | 88 | 3 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 6.25e-08 | 4 | 88 | 3 | 25518740 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 6.25e-08 | 4 | 88 | 3 | 12000766 | |
| Pubmed | Metalloproteinase Adamts16 Is Required for Proper Closure of the Optic Fissure. | 1.56e-07 | 5 | 88 | 3 | 29625437 | |
| Pubmed | 4.16e-07 | 59 | 88 | 5 | 21421844 | ||
| Pubmed | Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. | 5.44e-07 | 7 | 88 | 3 | 19915564 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 5.44e-07 | 7 | 88 | 3 | 19063725 | |
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 5.44e-07 | 7 | 88 | 3 | 19655386 | |
| Pubmed | 5.44e-07 | 7 | 88 | 3 | 12915301 | ||
| Pubmed | 5.80e-07 | 118 | 88 | 6 | 21078624 | ||
| Pubmed | 6.27e-07 | 64 | 88 | 5 | 22261194 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | JAG2 PLXNA3 FRAS1 MEGF6 MEGF8 ADAMTS7 MYO7A SCARB1 MYOM3 LAMB2 PAPLN UNKL PRAG1 LDLR | 7.10e-07 | 1105 | 88 | 14 | 35748872 |
| Pubmed | 8.66e-07 | 29 | 88 | 4 | 22613833 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 15661641 | ||
| Pubmed | 8.69e-07 | 8 | 88 | 3 | 10331952 | ||
| Pubmed | Integration of opposing semaphorin guidance cues in cortical axons. | 8.69e-07 | 8 | 88 | 3 | 22368082 | |
| Pubmed | 1.11e-06 | 210 | 88 | 7 | 16537572 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.28e-06 | 135 | 88 | 6 | 28675934 | |
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 11675412 | ||
| Pubmed | Semaphorin 6A in Retinal Ganglion Cells Regulates Functional Specialization of the Inner Retina. | 1.30e-06 | 9 | 88 | 3 | 38014224 | |
| Pubmed | 1.30e-06 | 9 | 88 | 3 | 19909241 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | TGFB1I1 JAG2 MEGF6 MEGF8 LAMB2 LTBP1 ADAMTSL4 MEGF11 MEGF10 STAB1 | 1.58e-06 | 560 | 88 | 10 | 21653829 |
| Pubmed | Plexin A3 and plexin A4 convey semaphorin signals during facial nerve development. | 1.85e-06 | 10 | 88 | 3 | 18804103 | |
| Pubmed | 1.85e-06 | 10 | 88 | 3 | 38713721 | ||
| Pubmed | 2.02e-06 | 146 | 88 | 6 | 27068509 | ||
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 2.55e-06 | 11 | 88 | 3 | 29337306 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TGFB1I1 MEGF6 MYO7A ALDH16A1 MYOM3 PLXNA4 MUC19 LRP2 LINC02901 SSPOP MEGF10 | 2.58e-06 | 736 | 88 | 11 | 29676528 |
| Pubmed | 2.64e-06 | 153 | 88 | 6 | 25037231 | ||
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 25839327 | ||
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 31690636 | ||
| Pubmed | On and off retinal circuit assembly by divergent molecular mechanisms. | 3.39e-06 | 12 | 88 | 3 | 24179230 | |
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 23991118 | ||
| Pubmed | 3.39e-06 | 12 | 88 | 3 | 28407732 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 3.39e-06 | 12 | 88 | 3 | 21270798 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 3.39e-06 | 12 | 88 | 3 | 25770910 | |
| Pubmed | 3.95e-06 | 164 | 88 | 6 | 32409323 | ||
| Pubmed | Functional assembly of accessory optic system circuitry critical for compensatory eye movements. | 4.40e-06 | 13 | 88 | 3 | 25959730 | |
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 10520995 | ||
| Pubmed | 4.40e-06 | 13 | 88 | 3 | 11604131 | ||
| Pubmed | Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. | 4.40e-06 | 13 | 88 | 3 | 22723296 | |
| Pubmed | A midline switch of receptor processing regulates commissural axon guidance in vertebrates. | 5.58e-06 | 14 | 88 | 3 | 20159958 | |
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 5.58e-06 | 14 | 88 | 3 | 17389516 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 5.76e-06 | 100 | 88 | 5 | 25807483 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 6.05e-06 | 101 | 88 | 5 | 20551380 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10884299 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 22015660 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 15331403 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24257605 | ||
| Pubmed | Interdependent Impact of Lipoprotein Receptors and Lipid-Lowering Drugs on HCV Infectivity. | 6.33e-06 | 2 | 88 | 2 | 34209751 | |
| Pubmed | Influence of maternal lipid profile on placental protein expression of LDLr and SR-BI. | 6.33e-06 | 2 | 88 | 2 | 17531953 | |
| Pubmed | A coding variant in SR-BI (I179N) significantly increases atherosclerosis in mice. | 6.33e-06 | 2 | 88 | 2 | 23722970 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 25983325 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 27373983 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 17905649 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 35484136 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 30920297 | ||
| Pubmed | The C-terminal region of laminin beta chains modulates the integrin binding affinities of laminins. | 6.33e-06 | 2 | 88 | 2 | 19147489 | |
| Pubmed | The mammalian Ced-1 ortholog MEGF10/KIAA1780 displays a novel adhesion pattern. | 6.33e-06 | 2 | 88 | 2 | 17498693 | |
| Pubmed | The role of ADAMTS-7 and ADAMTS-12 in the pathogenesis of arthritis. | 6.33e-06 | 2 | 88 | 2 | 19098927 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 38627162 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10764675 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 28888368 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 28522295 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 24619647 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 29599141 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 38881440 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 21876163 | ||
| Pubmed | Differential regulation of Notch ligands in dendritic cells upon interaction with T helper cells. | 6.33e-06 | 2 | 88 | 2 | 21352254 | |
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 34680102 | ||
| Pubmed | 6.33e-06 | 2 | 88 | 2 | 10712397 | ||
| Pubmed | Negative effects of ADAMTS-7 and ADAMTS-12 on endplate cartilage differentiation. | 6.33e-06 | 2 | 88 | 2 | 22247065 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 6.97e-06 | 15 | 88 | 3 | 15895400 | |
| Pubmed | 6.97e-06 | 15 | 88 | 3 | 31812516 | ||
| Pubmed | 8.56e-06 | 16 | 88 | 3 | 17356169 | ||
| Pubmed | 8.56e-06 | 16 | 88 | 3 | 17273555 | ||
| Pubmed | 8.56e-06 | 16 | 88 | 3 | 30579834 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 8.56e-06 | 16 | 88 | 3 | 18489001 | |
| Pubmed | 9.33e-06 | 407 | 88 | 8 | 12693553 | ||
| Pubmed | 1.04e-05 | 17 | 88 | 3 | 11683995 | ||
| Pubmed | 1.04e-05 | 17 | 88 | 3 | 10464288 | ||
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 1.04e-05 | 17 | 88 | 3 | 17626059 | |
| Pubmed | 1.10e-05 | 196 | 88 | 6 | 19334288 | ||
| Pubmed | Apoptotic cells in mouse blastocysts are eliminated by neighbouring blastomeres. | 1.24e-05 | 18 | 88 | 3 | 33927296 | |
| Pubmed | Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease. | 1.24e-05 | 18 | 88 | 3 | 24058526 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TGFB1I1 ADAMTS19 MYO7A RASSF1 ALDH16A1 YDJC RSPO4 LTBP1 CSMD1 ARPC1B PLXNA2 CRB2 PEAR1 | 1.44e-05 | 1242 | 88 | 13 | 30973865 |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 27397516 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 17296555 | ||
| Pubmed | Transcriptomic expression levels of the VHL, TIMP-3, and RASSF1A genes in renal tumors. | 1.90e-05 | 3 | 88 | 2 | 31773698 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 12906867 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 8806646 | ||
| Pubmed | The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. | 1.90e-05 | 3 | 88 | 2 | 19643179 | |
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 10814726 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 8307327 | ||
| Pubmed | 1.90e-05 | 3 | 88 | 2 | 18625214 | ||
| Interaction | SLURP1 interactions | PLXNA3 NID2 MEGF8 ADAMTS7 TIMP3 TLL2 SCARB1 LAMB1 LAMB2 LDLR | 7.10e-10 | 144 | 88 | 10 | int:SLURP1 |
| Interaction | IGFL3 interactions | 1.27e-09 | 75 | 88 | 8 | int:IGFL3 | |
| Interaction | NTN5 interactions | 5.63e-08 | 24 | 88 | 5 | int:NTN5 | |
| Interaction | LGALS1 interactions | JAG2 NID2 FRAS1 TENM3 LRP2 LAMB1 CR2 NAGPA LDLR ARPC1B PLXNA2 | 2.13e-07 | 332 | 88 | 11 | int:LGALS1 |
| Interaction | FBXO2 interactions | JAG2 PLXNA3 NID2 FRAS1 MEGF8 TENM3 ADAMTS7 SCARB1 LRP2 LAMB1 LAMB2 PLXNA2 | 2.24e-07 | 411 | 88 | 12 | int:FBXO2 |
| Interaction | DEFA1 interactions | 2.74e-07 | 100 | 88 | 7 | int:DEFA1 | |
| Interaction | FIBIN interactions | 6.65e-07 | 71 | 88 | 6 | int:FIBIN | |
| Interaction | PTPRK interactions | 1.07e-06 | 177 | 88 | 8 | int:PTPRK | |
| Interaction | SIRPD interactions | 2.07e-06 | 86 | 88 | 6 | int:SIRPD | |
| Interaction | SEMA5A interactions | 2.78e-06 | 7 | 88 | 3 | int:SEMA5A | |
| Interaction | ST14 interactions | 3.44e-06 | 207 | 88 | 8 | int:ST14 | |
| Interaction | HOXA1 interactions | TGFB1I1 JAG2 MEGF6 MEGF8 ZNF837 LAMB2 UNKL PLA2G10 LTBP1 ADAMTSL4 | 3.47e-06 | 356 | 88 | 10 | int:HOXA1 |
| Interaction | LYPD1 interactions | 5.40e-06 | 58 | 88 | 5 | int:LYPD1 | |
| Interaction | C1orf54 interactions | 8.55e-06 | 167 | 88 | 7 | int:C1orf54 | |
| Interaction | SDF2L1 interactions | 1.15e-05 | 322 | 88 | 9 | int:SDF2L1 | |
| Interaction | MSTN interactions | 1.26e-05 | 33 | 88 | 4 | int:MSTN | |
| Interaction | LAMB2 interactions | 1.57e-05 | 122 | 88 | 6 | int:LAMB2 | |
| Interaction | IL5RA interactions | 1.72e-05 | 124 | 88 | 6 | int:IL5RA | |
| Interaction | ATN1 interactions | 1.78e-05 | 187 | 88 | 7 | int:ATN1 | |
| Interaction | CFC1 interactions | 1.89e-05 | 126 | 88 | 6 | int:CFC1 | |
| Interaction | EDDM3A interactions | 2.01e-05 | 37 | 88 | 4 | int:EDDM3A | |
| Interaction | CRISP2 interactions | 2.75e-05 | 40 | 88 | 4 | int:CRISP2 | |
| Interaction | PSG8 interactions | 3.04e-05 | 41 | 88 | 4 | int:PSG8 | |
| Interaction | SEMA5B interactions | 3.52e-05 | 15 | 88 | 3 | int:SEMA5B | |
| Interaction | DEFB136 interactions | 4.03e-05 | 44 | 88 | 4 | int:DEFB136 | |
| Interaction | LY86 interactions | 4.62e-05 | 217 | 88 | 7 | int:LY86 | |
| Interaction | TIMP3 interactions | 4.65e-05 | 90 | 88 | 5 | int:TIMP3 | |
| Interaction | CMA1 interactions | 4.81e-05 | 46 | 88 | 4 | int:CMA1 | |
| Interaction | SEMA6B interactions | 5.24e-05 | 47 | 88 | 4 | int:SEMA6B | |
| Interaction | CCN6 interactions | 7.41e-05 | 19 | 88 | 3 | int:CCN6 | |
| Interaction | TRGV3 interactions | 9.77e-05 | 55 | 88 | 4 | int:TRGV3 | |
| Interaction | ADAM30 interactions | 1.05e-04 | 56 | 88 | 4 | int:ADAM30 | |
| Interaction | EDN3 interactions | 1.11e-04 | 108 | 88 | 5 | int:EDN3 | |
| Interaction | ADAMTS7 interactions | 1.12e-04 | 57 | 88 | 4 | int:ADAMTS7 | |
| Interaction | ZFP41 interactions | 1.12e-04 | 57 | 88 | 4 | int:ZFP41 | |
| Interaction | ATXN7 interactions | 1.16e-04 | 109 | 88 | 5 | int:ATXN7 | |
| Interaction | NXPH3 interactions | 1.20e-04 | 58 | 88 | 4 | int:NXPH3 | |
| Interaction | SEMA6D interactions | 1.34e-04 | 23 | 88 | 3 | int:SEMA6D | |
| Interaction | LYZL1 interactions | 1.68e-04 | 118 | 88 | 5 | int:LYZL1 | |
| Interaction | GPHA2 interactions | 1.73e-04 | 25 | 88 | 3 | int:GPHA2 | |
| Interaction | DNASE1L1 interactions | 1.82e-04 | 120 | 88 | 5 | int:DNASE1L1 | |
| Interaction | ADAMTS19 interactions | 1.87e-04 | 5 | 88 | 2 | int:ADAMTS19 | |
| Interaction | OIT3 interactions | 1.88e-04 | 65 | 88 | 4 | int:OIT3 | |
| Interaction | FBN2 interactions | 1.88e-04 | 65 | 88 | 4 | int:FBN2 | |
| Interaction | CACNA1A interactions | 2.04e-04 | 123 | 88 | 5 | int:CACNA1A | |
| Interaction | CBLN4 interactions | 2.37e-04 | 127 | 88 | 5 | int:CBLN4 | |
| Interaction | DEFA5 interactions | 2.50e-04 | 70 | 88 | 4 | int:DEFA5 | |
| Interaction | PRG2 interactions | 2.51e-04 | 285 | 88 | 7 | int:PRG2 | |
| Interaction | GPIHBP1 interactions | 2.93e-04 | 133 | 88 | 5 | int:GPIHBP1 | |
| Interaction | TAFAZZIN interactions | 2.94e-04 | 207 | 88 | 6 | int:TAFAZZIN | |
| Interaction | PLSCR4 interactions | 3.26e-04 | 75 | 88 | 4 | int:PLSCR4 | |
| Interaction | MFAP4 interactions | 3.59e-04 | 139 | 88 | 5 | int:MFAP4 | |
| Interaction | PRELP interactions | 3.64e-04 | 32 | 88 | 3 | int:PRELP | |
| Interaction | ADAMTS16 interactions | 3.90e-04 | 7 | 88 | 2 | int:ADAMTS16 | |
| Interaction | OS9 interactions | 3.97e-04 | 219 | 88 | 6 | int:OS9 | |
| Interaction | ZNF408 interactions | 4.36e-04 | 145 | 88 | 5 | int:ZNF408 | |
| Interaction | SCGB2A2 interactions | 4.37e-04 | 223 | 88 | 6 | int:SCGB2A2 | |
| Interaction | BCAN interactions | 5.18e-04 | 36 | 88 | 3 | int:BCAN | |
| Interaction | DLK2 interactions | 5.18e-04 | 36 | 88 | 3 | int:DLK2 | |
| Interaction | NID2 interactions | 5.49e-04 | 86 | 88 | 4 | int:NID2 | |
| Interaction | TOP3B interactions | JAG2 PLXNA3 FRAS1 MEGF6 MEGF8 ADAMTS7 MYO7A SCARB1 RECQL5 MYOM3 LAMB2 PAPLN UNKL PRAG1 ADAMTSL4 LDLR | 5.70e-04 | 1470 | 88 | 16 | int:TOP3B |
| Interaction | BTNL2 interactions | 5.91e-04 | 155 | 88 | 5 | int:BTNL2 | |
| Interaction | ADAMTS6 interactions | 6.65e-04 | 9 | 88 | 2 | int:ADAMTS6 | |
| Interaction | GGH interactions | 6.86e-04 | 243 | 88 | 6 | int:GGH | |
| Interaction | NPAP1 interactions | 8.29e-04 | 10 | 88 | 2 | int:NPAP1 | |
| Interaction | RNF123 interactions | TGFB1I1 MEGF6 MYO7A ALDH16A1 MYOM3 PLXNA4 MUC19 LRP2 LINC02901 SSPOP MEGF10 | 9.05e-04 | 824 | 88 | 11 | int:RNF123 |
| Cytoband | 1p36.3 | 3.26e-04 | 14 | 88 | 2 | 1p36.3 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.71e-11 | 19 | 60 | 6 | 50 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.82e-06 | 27 | 60 | 4 | 1253 | |
| GeneFamily | Plexins | 2.88e-06 | 9 | 60 | 3 | 683 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.80e-05 | 57 | 60 | 4 | 1179 | |
| GeneFamily | ADAMTS like | 2.25e-04 | 7 | 60 | 2 | 947 | |
| GeneFamily | Laminin subunits | 7.00e-04 | 12 | 60 | 2 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 8.25e-04 | 13 | 60 | 2 | 634 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 4.15e-03 | 29 | 60 | 2 | 782 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.17e-03 | 41 | 60 | 2 | 1298 | |
| Coexpression | NABA_MATRISOME | ADAMTS12 PLXNA3 ADAMTS19 NID2 HGFAC FRAS1 THBS2 MEGF6 MEGF8 ADAMTS7 TIMP3 ADAMTS6 PRG2 TLL2 ADAMTS16 PLXNA4 MUC19 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 ADAMTS5 SSPOP ADAMTSL4 MEGF11 PLXNA2 SVEP1 MEGF10 | 8.19e-21 | 1008 | 88 | 30 | MM17056 |
| Coexpression | NABA_MATRISOME | ADAMTS12 PLXNA3 ADAMTS19 NID2 HGFAC FRAS1 THBS2 MEGF6 MEGF8 ADAMTS7 TIMP3 ADAMTS6 PRG2 TLL2 ADAMTS16 PLXNA4 MUC19 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 ADAMTS5 SSPOP ADAMTSL4 MEGF11 PLXNA2 SVEP1 MEGF10 | 1.35e-20 | 1026 | 88 | 30 | M5889 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 PLXNA3 ADAMTS19 HGFAC MEGF6 MEGF8 ADAMTS7 TIMP3 ADAMTS6 TLL2 ADAMTS16 PLXNA4 MUC19 ADAMTS5 ADAMTSL4 MEGF11 PLXNA2 MEGF10 | 3.86e-11 | 738 | 88 | 18 | MM17058 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 FRAS1 THBS2 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 SSPOP SVEP1 | 4.52e-11 | 191 | 88 | 11 | MM17059 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS12 PLXNA3 ADAMTS19 HGFAC MEGF6 MEGF8 ADAMTS7 TIMP3 ADAMTS6 TLL2 ADAMTS16 PLXNA4 MUC19 ADAMTS5 ADAMTSL4 MEGF11 PLXNA2 MEGF10 | 5.13e-11 | 751 | 88 | 18 | M5885 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 FRAS1 THBS2 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 SSPOP SVEP1 | 5.98e-11 | 196 | 88 | 11 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | NID2 FRAS1 THBS2 PRG2 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 SSPOP SVEP1 | 1.15e-10 | 270 | 88 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | NID2 FRAS1 THBS2 PRG2 KCP LAMB1 LAMB2 PAPLN RSPO4 LTBP1 SSPOP SVEP1 | 1.42e-10 | 275 | 88 | 12 | M5884 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS19 ADAMTS7 TIMP3 ADAMTS6 TLL2 ADAMTS16 ADAMTS5 ADAMTSL4 | 1.11e-07 | 238 | 88 | 9 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS12 ADAMTS19 ADAMTS7 TIMP3 ADAMTS6 TLL2 ADAMTS16 ADAMTS5 ADAMTSL4 | 1.27e-07 | 242 | 88 | 9 | MM17062 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ADAMTS19 NID2 PDE3A TENM4 ADAMTS7 DLL4 RPRML TLL2 PLXNA4 LRP2 LAMB1 ADAMTS5 THSD7B MEGF11 SVEP1 PEAR1 | 5.10e-07 | 1074 | 88 | 16 | M1941 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | JAG2 TENM4 MEGF6 ADGRB3 PLXNA4 TENM1 MUC19 ADAMTS5 THSD7B CSMD1 CSMD3 PLXNA2 | 4.02e-06 | 703 | 88 | 12 | M39070 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 9.88e-06 | 40 | 88 | 4 | M5887 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN | 1.02e-05 | 13 | 88 | 3 | M27964 | |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 1.62e-05 | 15 | 88 | 3 | MM402 | |
| Coexpression | JONES_OVARY_THECA | 1.74e-05 | 46 | 88 | 4 | M48349 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.88e-05 | 163 | 88 | 6 | M12112 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 3.19e-05 | 365 | 88 | 8 | M39018 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | SCARF1 JAG2 NID2 MEGF6 TIE1 DLL4 SCARB1 LAMB1 LAMB2 LDLR ARPC1B STAB1 | 4.10e-05 | 888 | 88 | 12 | M39049 |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 4.69e-05 | 59 | 88 | 4 | M47989 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 6.46e-05 | 64 | 88 | 4 | M2572 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 8.68e-05 | 69 | 88 | 4 | M10165 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 1.15e-04 | 141 | 88 | 5 | M2898 | |
| Coexpression | KRAS.BREAST_UP.V1_DN | 1.23e-04 | 143 | 88 | 5 | M2887 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.23e-04 | 143 | 88 | 5 | M1935 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.23e-04 | 143 | 88 | 5 | MM819 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN | 1.79e-04 | 155 | 88 | 5 | M6675 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC | 1.85e-04 | 33 | 88 | 3 | M11654 | |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 2.07e-04 | 160 | 88 | 5 | M40233 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.10e-04 | 479 | 88 | 8 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.22e-04 | 483 | 88 | 8 | MM1082 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 2.28e-04 | 364 | 88 | 7 | M39057 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 3.39e-04 | 178 | 88 | 5 | M17079 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 3.48e-04 | 179 | 88 | 5 | M39308 | |
| CoexpressionAtlas | placenta | ADAMTS19 NID2 TENM3 TIE1 TIMP3 ADAMTS6 MYO7A DLL4 PRG2 SCARB1 LAMB1 ADAMTS5 ADAMTSL4 SVEP1 | 1.48e-10 | 349 | 87 | 14 | placenta |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | ADAMTS12 NID2 THBS2 TENM3 TIMP3 LAMB1 LAMB2 LTBP1 ADAMTS5 CSMD1 PLXNA2 SVEP1 | 2.65e-07 | 445 | 87 | 12 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | ADAMTS12 NID2 THBS2 PDE3A TENM3 TIMP3 LAMB1 LAMB2 ADAMTS5 CSMD1 SVEP1 | 2.51e-06 | 455 | 87 | 11 | GSM777055_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | ADAMTS12 THBS2 PDE3A TENM3 TIMP3 LAMB1 LAMB2 LTBP1 ADAMTS5 CSMD1 SVEP1 | 3.16e-06 | 466 | 87 | 11 | GSM777050_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | TGFB1I1 ADAMTS12 ADAMTS19 THBS2 PDE3A TENM4 TENM3 ADAMTS16 PLXNA4 LTBP1 THSD7B PLXNA2 SVEP1 | 9.56e-06 | 740 | 87 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.25e-05 | 439 | 87 | 10 | GSM777059_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.47e-05 | 354 | 87 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | SCARF1 TIE1 TIMP3 DLL4 PLXNA4 LAMB1 LTBP1 ADAMTS5 PLXNA2 STAB1 | 1.54e-05 | 450 | 87 | 10 | GSM777063_500 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 1.83e-05 | 459 | 87 | 10 | GSM777037_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.57e-05 | 437 | 87 | 9 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 1.05e-04 | 456 | 87 | 9 | GSM777032_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | TGFB1I1 NID2 HGFAC TENM4 TIMP3 ADAMTS6 ADGRB3 PLXNA4 LRP2 KCP ADAMTS5 SSPOP SVEP1 CRB2 | 1.37e-04 | 1094 | 87 | 14 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.69e-04 | 199 | 87 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.78e-04 | 201 | 87 | 6 | Arv_EB-LF_1000_K2 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | ADAMTS19 TYRP1 TENM4 DLL4 ADAMTS16 LRP2 KCP RSPO4 THSD7B CSMD1 SVEP1 MEGF10 CRB2 | 1.93e-04 | 992 | 87 | 13 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | ADAMTS19 FRAS1 RPRML TLL2 ADAMTS16 MUC19 PAPLN RSPO4 PKD1L2 CR2 MEGF11 MEGF10 CRB2 | 1.95e-04 | 993 | 87 | 13 | PCBC_SC_blastocyst_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | THBS2 PDE3A TENM3 ADAMTS6 ADGRB3 PLXNA4 LTBP1 ADAMTS5 CSMD3 PLXNA2 SVEP1 | 2.01e-04 | 734 | 87 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 2.09e-04 | 207 | 87 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | TGFB1I1 ADAMTS12 THBS2 TENM4 ADAMTS6 MYO7A RASSF1 PELI3 ADAMTS16 KCP TNFRSF13B LTBP1 SVEP1 STAB1 | 2.64e-04 | 1166 | 87 | 14 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.90e-04 | 311 | 87 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ADAMTS19 FRAS1 PDE3A TENM4 TENM3 SCARB1 PLXNA4 LAMB1 ADAMTS5 THSD7B SVEP1 | 3.26e-04 | 777 | 87 | 11 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.92e-04 | 327 | 87 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.70e-04 | 337 | 87 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_OSK-L-l-p53KD_vs_Mesoderm Day 30-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 4.92e-04 | 89 | 87 | 4 | PCBC_ratio_MESO-30_from-OSK-L-l-p53KD_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-method_episomal_vs_Mesoderm Day 30-method_NA-Confounder_removed-fold2.0_adjp0.05 | 4.92e-04 | 89 | 87 | 4 | PCBC_ratio_MESO-30_from-episomal_vs_MESO-30_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.41e-04 | 453 | 87 | 8 | GSM777067_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ADAMTS12 FRAS1 PDE3A TENM4 TENM3 ADAMTS6 PLXNA4 LTBP1 THSD7B PLXNA2 SVEP1 | 5.74e-04 | 831 | 87 | 11 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | TENM4 MEGF6 TIMP3 PRG2 PLXNA4 KCP TNFRSF13B LAMB1 LTBP1 CSMD3 SSPOP PLXNA2 | 6.48e-04 | 982 | 87 | 12 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | ADAMTS19 RPRML TLL2 ADAMTS16 MUC19 KCP RSPO4 PKD1L2 LINC02901 CR2 MEGF10 CRB2 | 6.72e-04 | 986 | 87 | 12 | PCBC_SC_fibroblast_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.16e-04 | 261 | 87 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | ratio_StemCell_vs_induced-DefinitiveEndoderm_top-relative-expression-ranked_100 | 7.36e-04 | 99 | 87 | 4 | PCBC_ratio_SC_vs_DE_100 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | ADAMTS12 SCARF1 GPR137 NID2 TIE1 MYO7A ALDH16A1 PELI3 ADAMTS16 LTBP1 ADAMTSL4 MEGF11 STAB1 | 7.44e-04 | 1143 | 87 | 13 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 7.75e-04 | 265 | 87 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.88e-04 | 480 | 87 | 8 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | Mesoderm Day 15-reprogram_NA_vs_Mesoderm Day 15-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 8.51e-04 | 179 | 87 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 15-method_NA_vs_Mesoderm Day 15-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 8.51e-04 | 179 | 87 | 5 | PCBC_ratio_MESO-15_from-ESC_vs_MESO-15_from-episomal_cfr-2X-p05 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | ADAMTS12 NID2 THBS2 ADAMTS16 PLXNA4 LAMB1 XPNPEP2 ADGRE2 LRRC15 STAB1 | 1.41e-12 | 168 | 88 | 10 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-10 | 182 | 88 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-10 | 184 | 88 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-10 | 184 | 88 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-10 | 184 | 88 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | ADAMTS12 NID2 THBS2 TENM4 ADAMTS6 ADAMTS16 LAMB1 LRRC15 LINC01561 | 1.31e-10 | 187 | 88 | 9 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-10 | 188 | 88 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | TGFB1I1 TYRP1 THBS2 ADAMTS6 ADGRB3 PLXNA4 LTBP1 ADAMTS5 THSD7B | 1.51e-10 | 190 | 88 | 9 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-10 | 190 | 88 | 9 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.51e-10 | 190 | 88 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-10 | 190 | 88 | 9 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-10 | 190 | 88 | 9 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | TGFB1I1 ADAMTS12 THBS2 TENM4 ADAMTS16 LAMB1 LTBP1 MEGF10 LRRC15 | 1.66e-10 | 192 | 88 | 9 | 67e845e513e76e820f55e2f0d15eb16f2944d05c |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | ADAMTS12 THBS2 TENM4 TENM3 ADAMTS16 ADGRB3 LAMB1 LTBP1 SVEP1 | 2.09e-10 | 197 | 88 | 9 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.28e-10 | 199 | 88 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-10 | 200 | 88 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-10 | 200 | 88 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.39e-10 | 200 | 88 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.52e-09 | 178 | 88 | 8 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.41e-09 | 185 | 88 | 8 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.87e-09 | 188 | 88 | 8 | 74f7d216209cabdc96b2d46685b0ae017fdcc8fc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.87e-09 | 188 | 88 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.03e-09 | 189 | 88 | 8 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-09 | 191 | 88 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.38e-09 | 191 | 88 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-09 | 192 | 88 | 8 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.56e-09 | 192 | 88 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-09 | 192 | 88 | 8 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-09 | 192 | 88 | 8 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.75e-09 | 193 | 88 | 8 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 5.36e-09 | 196 | 88 | 8 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-09 | 196 | 88 | 8 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-09 | 196 | 88 | 8 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 5.36e-09 | 196 | 88 | 8 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-09 | 197 | 88 | 8 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-09 | 197 | 88 | 8 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.58e-09 | 197 | 88 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.58e-09 | 197 | 88 | 8 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.58e-09 | 197 | 88 | 8 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-09 | 198 | 88 | 8 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 5.81e-09 | 198 | 88 | 8 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-09 | 198 | 88 | 8 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.81e-09 | 198 | 88 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.81e-09 | 198 | 88 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-09 | 198 | 88 | 8 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.04e-09 | 199 | 88 | 8 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.04e-09 | 199 | 88 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.04e-09 | 199 | 88 | 8 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 6.04e-09 | 199 | 88 | 8 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | COVID-19_Mild-Neu_0|World / 5 Neutrophil clusters in COVID-19 patients | 1.25e-08 | 140 | 88 | 7 | 93f024473b1bb3bf93ae776fd6a8fc5e93d013f0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.72e-08 | 164 | 88 | 7 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.39e-08 | 168 | 88 | 7 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.58e-08 | 169 | 88 | 7 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-08 | 173 | 88 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-08 | 176 | 88 | 7 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-08 | 176 | 88 | 7 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-08 | 177 | 88 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-08 | 177 | 88 | 7 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.28e-08 | 177 | 88 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-08 | 177 | 88 | 7 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.28e-08 | 177 | 88 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.79e-08 | 179 | 88 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.32e-08 | 181 | 88 | 7 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.32e-08 | 181 | 88 | 7 | 3aa81ac64d0cc9a74fbfa71e2176740548e7cd06 | |
| ToppCell | 5'-Adult-Appendix-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.32e-08 | 181 | 88 | 7 | 997ba1be2824b00d684f2163d0114656ed11fa53 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.32e-08 | 181 | 88 | 7 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 7.32e-08 | 181 | 88 | 7 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.32e-08 | 181 | 88 | 7 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | 5'-Adult-Appendix-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.32e-08 | 181 | 88 | 7 | e6b7e8dd5c13cc10ba22f2f5a8c669486f934bdc | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.50e-08 | 185 | 88 | 7 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.50e-08 | 185 | 88 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.50e-08 | 185 | 88 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.15e-08 | 187 | 88 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.15e-08 | 187 | 88 | 7 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.15e-08 | 187 | 88 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.15e-08 | 187 | 88 | 7 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.49e-08 | 188 | 88 | 7 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.49e-08 | 188 | 88 | 7 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.49e-08 | 188 | 88 | 7 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.84e-08 | 189 | 88 | 7 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.02e-07 | 190 | 88 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-07 | 190 | 88 | 7 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 190 | 88 | 7 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 190 | 88 | 7 | b0c9dae8189d407c94964c6bfe3ef92035245357 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.02e-07 | 190 | 88 | 7 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-07 | 190 | 88 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 190 | 88 | 7 | ee63dc04e91ad49aa7820c98e97261176ecebaa6 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-07 | 190 | 88 | 7 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 190 | 88 | 7 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | facs-SCAT-Fat-18m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 190 | 88 | 7 | 0e50808bfc3d0820524c8470ae3e8250819d65b2 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-07 | 190 | 88 | 7 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.02e-07 | 190 | 88 | 7 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-07 | 190 | 88 | 7 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-07 | 191 | 88 | 7 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-07 | 191 | 88 | 7 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-07 | 191 | 88 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-07 | 191 | 88 | 7 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 191 | 88 | 7 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-07 | 191 | 88 | 7 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-07 | 191 | 88 | 7 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| Computational | Ovary genes. | 2.31e-04 | 368 | 49 | 8 | MODULE_1 | |
| Computational | Metal / Ca ion binding. | 3.31e-04 | 133 | 49 | 5 | MODULE_324 | |
| Drug | chondroitin sulfate | ADAMTS12 THBS2 ADAMTS7 TIMP3 PRG2 ADAMTS16 LAMB1 LAMB2 RSPO4 LTBP1 ADAMTS5 ADGRE2 ADAMTSL4 | 6.68e-09 | 413 | 88 | 13 | CID000024766 |
| Drug | DB04780 | ADAMTS12 KLK15 NID2 ADAMTS7 LAMB1 LAMB2 RSPO4 ADAMTS5 ADAMTSL4 | 2.01e-08 | 170 | 88 | 9 | CID005459389 |
| Drug | BM165 | 9.00e-06 | 11 | 88 | 3 | CID003352881 | |
| Drug | angiogenesis inhibitor | 1.04e-05 | 128 | 88 | 6 | CID002812173 | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.07e-05 | 195 | 88 | 7 | 6035_UP | |
| Disease | carotene diol (2) measurement | 2.51e-05 | 3 | 86 | 2 | EFO_0800171 | |
| Disease | carotene diol (1) measurement | 2.51e-05 | 3 | 86 | 2 | EFO_0800170 | |
| Disease | Schistosomiasis | 2.51e-05 | 3 | 86 | 2 | C0036323 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 5.02e-05 | 4 | 86 | 2 | EFO_0803113 | |
| Disease | IMMUNODEFICIENCY, COMMON VARIABLE, 2 | 8.35e-05 | 5 | 86 | 2 | 240500 | |
| Disease | Urinary Bladder Diseases | 8.35e-05 | 5 | 86 | 2 | C0005686 | |
| Disease | Immunodeficiency, common variable, 2 | 8.35e-05 | 5 | 86 | 2 | cv:C3150354 | |
| Disease | aspartate aminotransferase measurement | ADAMTS12 HGFAC PDE3A ADAMTS6 MYO7A SCARB1 MUC19 THSD7B CSMD1 PRAG1 | 3.00e-04 | 904 | 86 | 10 | EFO_0004736 |
| Disease | Parkinson's disease symptom measurement | 3.76e-04 | 48 | 86 | 3 | EFO_0600011 | |
| Disease | myopathy (implicated_via_orthology) | 3.76e-04 | 48 | 86 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Immunoglobulin Deficiency, Late-Onset | 4.54e-04 | 11 | 86 | 2 | C2936665 | |
| Disease | Acquired Hypogammaglobulinemia | 4.54e-04 | 11 | 86 | 2 | C2936664 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 5.93e-04 | 56 | 86 | 3 | EFO_0022279 | |
| Disease | Common variable immunodeficiency | 6.41e-04 | 13 | 86 | 2 | cv:C0009447 | |
| Disease | triacylglycerol 48:4 measurement | 7.47e-04 | 14 | 86 | 2 | EFO_0010407 | |
| Disease | free cholesterol in very large HDL measurement | 7.98e-04 | 62 | 86 | 3 | EFO_0022273 | |
| Disease | Proteinuria | 8.60e-04 | 15 | 86 | 2 | HP_0000093 | |
| Disease | caffeine measurement | 8.60e-04 | 15 | 86 | 2 | EFO_0021177 | |
| Disease | Common Variable Immunodeficiency | 8.60e-04 | 15 | 86 | 2 | C0009447 | |
| Disease | glycerate measurement | 8.60e-04 | 15 | 86 | 2 | EFO_0021029 | |
| Disease | employment status | 8.60e-04 | 15 | 86 | 2 | EFO_0005241 | |
| Disease | fish consumption measurement | 8.76e-04 | 64 | 86 | 3 | EFO_0010139 | |
| Disease | Child Behaviour Checklist assessment | 1.25e-03 | 18 | 86 | 2 | EFO_0005661 | |
| Disease | peritonsillar abscess | 1.25e-03 | 18 | 86 | 2 | EFO_0007429 | |
| Disease | memory performance | 1.26e-03 | 409 | 86 | 6 | EFO_0004874 | |
| Disease | cortisol measurement | 1.54e-03 | 20 | 86 | 2 | EFO_0005843 | |
| Disease | cerebellum white matter volume change measurement, age at assessment | 1.54e-03 | 20 | 86 | 2 | EFO_0008007, EFO_0021498 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.64e-03 | 291 | 86 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.67e-03 | 80 | 86 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 2.04e-03 | 23 | 86 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.04e-03 | 23 | 86 | 2 | C4521256 | |
| Disease | linoleic acid measurement | 2.17e-03 | 186 | 86 | 4 | EFO_0006807 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 2.22e-03 | 312 | 86 | 5 | EFO_0004612, EFO_0010351 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.31e-03 | 315 | 86 | 5 | EFO_0004612, EFO_0008591 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.31e-03 | 315 | 86 | 5 | EFO_0004574, EFO_0004612 | |
| Disease | TEMPS-A questionnaire | 2.41e-03 | 25 | 86 | 2 | EFO_0004783 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 2.51e-03 | 321 | 86 | 5 | EFO_0004612, EFO_0004639 | |
| Disease | L lactate dehydrogenase measurement | 2.61e-03 | 26 | 86 | 2 | EFO_0004808 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.82e-03 | 330 | 86 | 5 | EFO_0004529, EFO_0004612 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSCDFESGLCGWSHL | 971 | Q6UXC1 | |
| EWTSCSRSCGPGTQH | 731 | Q6UY14 | |
| GLWSGSETRCLAGHC | 2666 | Q96PZ7 | |
| WSHPLPTCDALCGGD | 1056 | Q7Z407 | |
| CQADGTWSGSSPHCI | 3331 | Q7Z407 | |
| SVPTGGCKESGCSWH | 461 | Q8IZ83 | |
| GCGHWATTGCSTIGT | 491 | Q9UHX3 | |
| AHGGSECRGPWAESR | 431 | O60242 | |
| AGGGTSAPWRHRSHC | 116 | Q9UNA0 | |
| SCGWVHGVCFSASGS | 201 | O15143 | |
| HGTCSTPWQCTCDEG | 261 | Q9NR61 | |
| GHWTECSVTCGTGIR | 831 | P58397 | |
| SAGPWAECSHTCGKG | 991 | Q8TE57 | |
| HQPWSECSATCAGGV | 846 | Q9UKP5 | |
| TSSWRECSEACGGGE | 1526 | Q9UKP4 | |
| CGHEAWPESSRPCGT | 1611 | Q9UKP4 | |
| PAGPATHTWCDLCGD | 56 | Q9NS23 | |
| HTSWEDCDATCGGGE | 921 | Q8TE59 | |
| TLVRHGCDATCWGPG | 706 | Q9P2R3 | |
| GGTNCSSACDGDHWG | 131 | Q96KG7 | |
| SSACDGDHWGPHCTS | 136 | Q96KG7 | |
| PVDGSCTCKAGWHGV | 466 | Q96KG7 | |
| GWHGVDCSIRCPSGT | 476 | Q96KG7 | |
| DCSIRCPSGTWGFGC | 481 | Q96KG7 | |
| PGWSGVHCDSVCAEG | 561 | Q96KG7 | |
| DTCHCEPGWGGPDCS | 116 | A6BM72 | |
| GPDCSSGCDSDHWGP | 126 | A6BM72 | |
| SGCDSDHWGPHCSNR | 131 | A6BM72 | |
| TGACTCQPGWSGHHC | 376 | A6BM72 | |
| GSCSCTPGWLGDTCE | 506 | A6BM72 | |
| PVTGHCCCLAGWTGI | 546 | A6BM72 | |
| EDGACHCTPGWTGLF | 721 | A6BM72 | |
| AVCHESCAGCWGPTE | 511 | Q86XX4 | |
| ACGPGWEGPRCEAHV | 1081 | Q5IJ48 | |
| GEDVWRCPGCGDHIA | 6 | P53671 | |
| GHCEDEGCSWEHSRG | 326 | Q96N19 | |
| CHCPSGWSGPTCALD | 371 | Q9Y219 | |
| PPEQAHSCGWGTEGC | 6 | Q4VX62 | |
| HSCGWGTEGCPCLRS | 11 | Q4VX62 | |
| TCGECLSSGDPHCGW | 516 | O75051 | |
| LSSGDPHCGWCALHN | 521 | O75051 | |
| LGSGDPHCGWCVLRH | 501 | P51805 | |
| GSGDPHCGWCVLHNT | 521 | Q9HCM2 | |
| CPHPGEACVVSGWGL | 131 | Q9H2R5 | |
| GRCCHGWSKAPGSQR | 171 | Q14766 | |
| VGWRTGLCEHSCPSG | 1066 | Q7Z5P9 | |
| ASPRDSGCRGCWGDL | 36 | Q14432 | |
| TGACTCTPGWHGAHC | 506 | Q5VY43 | |
| HPSNGTCYCLAGWTG | 631 | Q5VY43 | |
| QDGSCICPLGWTGHH | 676 | Q5VY43 | |
| WTGHHCLEGCPLGTF | 686 | Q5VY43 | |
| RGPGTLGWCVHNESC | 626 | Q7Z7M0 | |
| PHGGCRGWDDSVHSE | 986 | Q7Z7M0 | |
| TWGEHCERCRPGSFG | 1186 | Q7Z7M0 | |
| EHWGLSNDLDGCRPC | 496 | P07942 | |
| GCDRCLPGHWGLSHD | 501 | P55268 | |
| GSGHCIPADWRCDGT | 36 | P98164 | |
| LCWGRGHGCGQEALS | 206 | Q6TCH4 | |
| LGGHGQPRDAIDWCC | 71 | O15496 | |
| FGGRTWCEGTRHTAC | 231 | Q04756 | |
| DTCGHIGRGPSSEWV | 126 | Q7Z442 | |
| CETVGHPSDLWAEGC | 826 | Q86Y26 | |
| GSTGFCWCVDPDGHE | 976 | Q14112 | |
| WSRGGHCVALCTRGG | 191 | P13727 | |
| QCRSDSKGHGSWSGP | 761 | P20023 | |
| EGASWRGLPHCSCAE | 46 | Q9NYF3 | |
| GGATSSHCPQVGCWT | 146 | Q8N813 | |
| FVGHCGADCGWDRGE | 301 | Q9BUB5 | |
| ATGHCSCAPGWTGFS | 841 | O75095 | |
| DHVSGACTCPAGWRG | 926 | O75095 | |
| AGWRGTFCEHACPAG | 936 | O75095 | |
| PVSGHCACPEGWAGL | 1056 | O75095 | |
| GNRTHGLGTWLGCCP | 26 | Q8N4K4 | |
| GWSPCTHNGKTCGSA | 146 | Q2I0M5 | |
| VRTCCPGWGGAHCTE | 91 | A2VEC9 | |
| PWSHCSRSCGGGLRS | 3261 | A2VEC9 | |
| WGAGLAYHGCPSECT | 16 | Q8TF66 | |
| TCQGCTEGGSHWEHG | 251 | Q6ZWJ8 | |
| CPFCGAWLTGEHGCV | 446 | Q8N2H9 | |
| QCTGHFWRGPGCDEL | 346 | Q9UK23 | |
| GSNCSEECPLGWHGP | 386 | Q9UK23 | |
| CRSGSGHCWGLRSTL | 511 | Q8WTV0 | |
| CECSPGWEGDHCTIA | 741 | Q9UKZ4 | |
| DCPPGWTGSRCHTAV | 3521 | Q4LDE5 | |
| PDTGHCQRCDPGWLG | 321 | Q14162 | |
| LCRGPSCHGLGHWNT | 146 | Q6PIS1 | |
| GWGHLHAAVTGASCC | 86 | Q8N1V8 | |
| GGDCSRNSCLAWHRG | 121 | Q96EG3 | |
| RCESEADWHGLCGPQ | 976 | O94762 | |
| SGHNCGTCRPGWRGA | 106 | P17643 | |
| CHSCLSGLWEIPGES | 36 | Q6AZZ1 | |
| YRGDGWHCECSPGSC | 141 | P07911 | |
| WHCECSPGSCGPGLD | 146 | P07911 | |
| HDSSSWSDCCGGGGR | 456 | Q8N7X1 | |
| GSWSDCSAECGGGHQ | 311 | O95428 | |
| GCCPDGHTASLGPQW | 636 | O95428 | |
| TCDRFSGCVCPSGWH | 326 | P35590 | |
| SWPDHGGCEHRCVNT | 581 | Q9Y6L7 | |
| GCGEGPDAFSCSWER | 256 | A8MPS7 | |
| SLGCWCGVEHEETPS | 71 | Q13398 | |
| GECHCSVGWGGTNCE | 676 | Q6N022 | |
| GLCSCDPSWTGHDCS | 711 | Q6N022 | |
| HGVCVGGTCRCEDGW | 736 | Q6N022 | |
| RDGKCECSPGWNGEH | 771 | Q6N022 | |
| ECSPGWNGEHCTIAH | 776 | Q6N022 | |
| SGSCFCDEGWTGPRC | 2036 | Q9NY15 | |
| DGWSCRARNPCTDGH | 2126 | Q9NY15 | |
| HCSPGWGGSNCEILK | 631 | Q9P273 | |
| RGRHGGRDCSPTCWE | 276 | Q86YV5 | |
| DEWGEPSRCDGGDGC | 256 | Q9H9P5 | |
| AHFCPDTSLWSCGGQ | 416 | Q3C1V9 | |
| SGGHEGHCKPWTDCT | 121 | Q9Y5U5 | |
| PDPTCAGRWGCHTRT | 251 | O14836 | |
| AWHPEHFVCGGCSTA | 246 | O43294 | |
| CACAWGHTKPVDLGG | 16 | O43895 | |
| CPSCLHSVDGEEGWS | 371 | P35442 | |
| CGPGGVQSRAVWCFH | 56 | Q9C0I4 | |
| GPSCSWEAEGLHCSC | 461 | Q96RL6 | |
| LGDWGAEACTCSPSH | 16 | P35625 | |
| SGECIHSSWRCDGGP | 206 | P01130 | |
| LGCSDLGCAAPHSGW | 1531 | Q13402 | |
| SGEWIACHEAPGGTC | 416 | Q5VTT5 |